Yatsarwar kwayar cuta ta numfashi a cikin hunturu
Matakan don rage watsa SARS-Cov-2 sun kasance mai tasiri wajen rage yaduwar wasu ƙwayoyin ƙwayoyin cuta na jihoji. Kamar yadda ƙasashe da yawa sun rage amfani da irin waɗannan matakan, SARS-2-2 zai kewaya tare da wasu ƙwayoyin cuta na numfashi, ƙara yiwuwar yiwuwar hadin gwiwa.
Masana sun yi hasashen cewa na iya zama annoba sau uku a wannan lokacin hunturu saboda ƙwayar cuta ta ruwa (RSV) tare da cutar ƙwayar ta SARS-2 tare da cutar ƙwayar cuta ta SARS-2. Yawan lokuta na mura da RSV a wannan shekara sun fi ta wannan lokacin a shekarun da suka gabata. Sabbin bambance-bambancen Ba.4 kuma ba.5 na kwayar cutar ta SARS-2 sun sake tsananta wa annoba sake.
A ranar "ranar farin ciki ta Duniya ta" ranar sanyi ta 2022 "a ranar 1 ga Nuwamba, 2022, Zhong Nan, Cibiyar Masarautar Injiniya ta kasar Sin, kuma ta bincika sabon bincike da hukunci kan halin da ake ciki yanzu."Duniya har yanzu tana fuskantar hadarin da annobar ta SARS-2 da cutar mura." Ya nuna, "Musamman ma wannan hunturu ne, har yanzu yana buƙatar ƙarfafa bincike kan abubuwan kimiyya na rigakafin rigakafin cutar mura da sarrafawa."Dangane da ƙididdigar CDC ta Amurka CDC, yawan ziyartar asibitoci na numfashi a cikin Amurka ta karu sosai saboda haɗuwa da cututtukan jijiyoyin jiki.
Theara yawan gano RSV da Sashin gaggawa na sashen gaggawa da asibiti a yawancin yankuna na Amurka, tare da wasu yankuna kusa da matakan ƙwayoyin cuta. A halin yanzu, yawan adadin kamuwa da cututtukan RSV a cikin Amurka ya kai ga mafi girman iko cikin shekaru 25, yana haifar da asibitocin yara da za a rufe, kuma an rufe wasu makarantu.
Bayyanar cutar mura da aka barke a Australia a watan Afrilun wannan shekara kuma an kwashe kusan watanni 4. Kamar yadda 25 ga Satumba, akwai karar dakin gwaje-gwaje 224,565 na mura, sakamakon mutuwar mutane 305. Da bambanci, ƙarƙashin ƙwayar rigakafin cutar sash-2-2, za a sami kusan maganganun mura 21,000 a Australia a cikin 2020 kuma ƙasa da 1,000 a 2021.
Rahoton sati na 35 na Cibiyar Kasar Sin a shekarar 2022 ya nuna cewa yawan lamuran arewacin a shekarar 2019-2021 na 4 a jere, kuma lamarin zai zama mafi mahimmanci. Kamar yadda tsakiyar Yuni, yawan lokuta da mura-kamar yadda aka ba da rahoton cewa a Guangzhou ya karu da sau 10.38 idan aka kwatanta da bara.
Sakamakon binciken da ake amfani da shi na binciken da LACET ta fitar da lafiyar duniya a watan Oktoba ya nuna cewa yawan yawan mutanen da mura da aka kwatanta da a gaban annoba. Hakanan ya annabta cewa amplitude na lokacin sanyi na 2022 zai karu da sau 1-5, da girman annoba zai karu ta sau 1-4.
212,466 manya tare da kamuwa da SARS-2 wanda aka shigar a asibiti. Ana yin gwaje-gwaje don cututtukan da key co-coires don marasa lafiya 6,965 tare da SARS-2-2. An gano coo-kamuwa da cuta a cikin 583 (8 · 4%) marasa lafiyar mura, marasa lafiya 220 suna da ƙwayar cuta ta hanyar numfashi, kuma marasa lafiya suna da adenviruses.
Ciyar da cuta tare da ƙwayoyin cuta masu sanyin mura suna da alaƙa da ƙara haɓakar karɓar iska mai amfani idan aka kwatanta da SARS-COV-2 Mono-COCK-COCK. Ciyar da COV-2 tare da ƙwayoyin cuta mura da adenoviruses duk suna da alaƙa da ƙara rashin rashin mutuwa. A ko don samun iska na yau da kullun a cikin mura da co-kamuwa da cuta Co-kamuwa da 4.14 (95% ci 2.00-8% ci 2.00-8%, p = 0.0001). A ko na mace-mace da mace-mace A cikin asibitoci a cikin mura da marasa lafiya masu cutar ta 2.35 (95% ci 1.07-5.12, p = 0.031). The ko na mace-mace mace a Adenovirus Co-Cutar Mahaifin Maha Mahaifafawa ya 1.6 (95% ci 1.03-2.44, p = 0.033).
Sakamakon wannan binciken a fili ya gaya mana cewa c-kamewa tare da ƙwayoyin cuta 2-2 da cutar mura ta da matsala ce ta haɗari.
Kafin barkewar barkewar SARS-2, alamomin ƙwayoyin cuta daban-daban sun yi kama sosai, amma hanyoyin kulawa sun bambanta. Idan marasa lafiya ba sa dogara da gwaji da yawa, lura da ƙwayoyin cuta na numfashi za su kara rikitarwa, kuma zai iya sauƙaƙa ɓata albarkatun asibiti yayin babban yanayi-m yanayi. Saboda haka, gwajin haɗin gwiwa da yawa suna taka muhimmiyar rawa a cikin cutar asibiti, kuma likitoci sun sami damar bayar da gane-bambancen ganewar asali na cututtukan cututtukan cututtukan ruwa da cututtukan swab guda ɗaya.
Macro & micro-gwajin sashi-cop-2 na numfashi
Macro & micro-gwajin yana da dandamali na fasaha kamar mai iya mai haske PCR, amperesthal Repectation, kayan rigakafi, da kuma samar da kayayyakin ganowa SARS-2-2-2 2. Duk samfuran sun samo takaddun EU Cate, tare da ingantaccen tsarin aikin da kuma kwarewar mai amfani mai amfani.
1. Gaskiya lokaci mai kyalli
Kula da ciki: Cikakken kula da tsarin gwaji don tabbatar da ingancin gwaje-gwajen.
Babban inganci: PCR na yau da kullun PCR na ainihi na musamman don SARS-2-2, mura a, cirs Bycoplasma, da ƙwayar cuta ta numfashi.
Babban hankali: Kafi 300 kofe / ml don SARS-Cov-2, 500copopies / ml don mycopasma virus, 500copopies / ml don mycopasma circoni, da 500copopies / ml don adenviruse, da 500copopies / ml for adenovirus.
2. SARKIN-COV-2 / Abincura Acid Acid Acid (my
Kula da ciki: Cikakken kula da tsarin gwaji don tabbatar da ingancin gwaje-gwajen.
Babban inganci: LOOX Real PCR-lokaci PCR ya gano takamaiman manufa don SARS-Cov-2, mura a da mura B.
Babban hankali: Kafi 300 kofe / ml na SARS-2-2,500copies / ml na LFV A da 500copopies / ml na LFV B.
3. SARS-COV-2, mura da m mura b antigen kayan gini (imtarchromography)
Sauki don amfani
Takuwar zazzabi & Adana a 4-30 ° ℃
Babban abin sani da takamaiman
| Sunan Samfuta | Gwadawa |
| Real Time Fluorescent rt-PCR Kit don gano nau'ikan cututtukan jini iri uku | 20 Gwaji / Kit,48 gwaji / Kit,50 Gwaji / Kit |
| SARS-2 / Abincin ku / Abincin mura | 48 gwaji / Kit,50 Gwaji / Kit |
| SARS-COV-2, Abun Motar A da Abincin Kudi Antigen Kit (Immunochromato) | 1 Gwaji / Kit,20 Gwaji / Kit |
Lokaci: Dec-09-2022